Advanced search
Publication Cover
Expert Review of Respiratory Medicine Volume 5, 2011 - Issue 4
Submit an article Journal homepage
363
Views
23
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY program

Luca Richeldi University of Modena & Reggio Emilia, Modena, Italy; University of Modena & Reggio Emilia, Modena, Italy
&
Roland M du Bois Imperial College, London, SW7 2AZ, UK. [email protected]; Imperial College, London, SW7 2AZ, UK. [email protected]
Pages 473-481 | Published online: 09 Jan 2014

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sarah MacIsaac & Martin Kolb. (2021) Interstitial lung disease. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 5:2, pages 93-96.
Read now
Antoni Xaubet, Anna Serrano-Mollar & Julio Ancochea. (2014) Pirfenidone for the treatment of idiopathic pulmonary fibrosis. Expert Opinion on Pharmacotherapy 15:2, pages 275-281.
Read now

Articles from other publishers (21)

Andrew D. Hahn, Katie J. Carey, Gregory P. Barton, Luis A. Torres, Jeff Kammerman, Robert V. Cadman, Kristine E. Lee, Mark L. Schiebler, Nathan Sandbo & Sean B. Fain. (2022) Hyperpolarized 129 Xe MR Spectroscopy in the Lung Shows 1-year Reduced Function in Idiopathic Pulmonary Fibrosis . Radiology 305:3, pages 688-696.
Crossref
Jukun Wang, Ke Han, Chao Zhang, Xin Chen, Yu Li, Linzhong Zhu & Tao Luo. (2021) Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients . Bioscience Reports 41:5.
Crossref
Elaina Melton & Hongyu Qiu. (2020) Interleukin-36 Cytokine/Receptor Signaling: A New Target for Tissue Fibrosis. International Journal of Molecular Sciences 21:18, pages 6458.
Crossref
Feifei Feng, Peng Cheng, Shaohua Xu, Nannan Li, Hui Wang, Ying Zhang & Wei Wang. (2020) Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signaling. Chemico-Biological Interactions 319, pages 109024.
Crossref
Bryan M.H. Keng, Fei Gao, See Hooi Ewe, Ru San Tan, Louis L.Y. Teo, Bei Qi Xie, Woon‐Puay Koh & Angela S. Koh. (2019) Galectin‐3 as a candidate upstream biomarker for quantifying risks of myocardial ageing. ESC Heart Failure 6:5, pages 1068-1076.
Crossref
Shu-Min Li, Yang Lin & Shan-Shan Liang. (2019) Efficacy of pirfenidone for the treatment of pulmonary fibrosis. Medicine 98:17, pages e15407.
Crossref
Young-Im Kim, Hyun-Woo Shin, Yang-Sook Chun, Chung-Hyun Cho, Jaemoon Koh, Doo Hyun Chung & Jong-Wan Park. (2018) Epithelial cell-derived cytokines CST3 and GDF15 as potential therapeutics for pulmonary fibrosis. Cell Death & Disease 9:5.
Crossref
Kimiyuki Ikeda, Masanori Shiratori, Hirofumi Chiba, Hirotaka Nishikiori, Keiki Yokoo, Atsushi Saito, Yoshihiro Hasegawa, Koji Kuronuma, Mitsuo Otsuka, Gen Yamada & Hiroki Takahashi. (2017) Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone. Respiratory Medicine 131, pages 184-191.
Crossref
Jingjin Yang, Ting Wang, Yan Li, Wenxi Yao, Xiaoming Ji, Qiuyun Wu, Lei Han, Ruhui Han, Weiwen Yan, Jiali Yuan & Chunhui Ni. (2016) Earthworm extract attenuates silica-induced pulmonary fibrosis through Nrf2-dependent mechanisms. Laboratory Investigation 96:12, pages 1279-1300.
Crossref
N.N. Do & S.A. Eming. (2016) Skin fibrosis: Models and mechanisms. Current Research in Translational Medicine 64:4, pages 185-193.
Crossref
Akihiro KUMA, Masahito TAMURA & Yutaka OTSUJI. (2016) Mechanism of and Therapy for Kidney Fibrosis. Journal of UOEH 38:1, pages 25-34.
Crossref
Isha Agarwal, Alice Arnold, Nicole L. Glazer, Eddy Barasch, Luc Djousse, Annette L. Fitzpatrick, John S. Gottdiener, Joachim H. Ix, Richard A. Jensen, Jorge R. Kizer, Eric B. Rimm, David S. Siscovick, Russell P. Tracy, Tien Y. Wong & Kenneth J. Mukamal. (2015) Fibrosis-related biomarkers and large and small vessel disease: The Cardiovascular Health Study. Atherosclerosis 239:2, pages 539-546.
Crossref
Fernando Rodríguez-Pascual, Oscar Busnadiego & José González-Santamaría. (2014) The profibrotic role of endothelin-1: Is the door still open for the treatment of fibrotic diseases?. Life Sciences 118:2, pages 156-164.
Crossref
Isha AgarwalNicole L. GlazerEddy BaraschMary L. BiggsLuc DjousseAnnette L. FitzpatrickJohn S. GottdienerJoachim H. IxJorge R. KizerEric B. RimmDavid S. SicovickRussell P. TracyKenneth J. Mukamal. (2014) Fibrosis-Related Biomarkers and Incident Cardiovascular Disease in Older Adults. Circulation: Arrhythmia and Electrophysiology 7:4, pages 583-589.
Crossref
Isha Agarwal, Nicole L. Glazer, Eddy Barasch, Mary L. Biggs, Luc Djoussé, Annette L. Fitzpatrick, John S. Gottdiener, Joachim H. Ix, Jorge R. Kizer, Eric B. Rimm, David S. Siscovick, Russell P. Tracy, Susan J. Zieman & Kenneth J. Mukamal. (2014) Fibrosis-Related Biomarkers and Risk of Total and Cause-Specific Mortality. American Journal of Epidemiology 179:11, pages 1331-1339.
Crossref
Solange Moll, Lyubov Chaykovska, Matthias Meier, David C. Budd, Ivan Formentini, Silvia Pomposiello & Marco Prunotto. (2013) Targeting the epithelial cells in fibrosis: a new concept for an old disease. Drug Discovery Today 18:11-12, pages 582-591.
Crossref
Matthew C. Lucas & David C. Budd. 2013. 149 167 .
Thomas A Wynn & Thirumalai R Ramalingam. (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nature Medicine 18:7, pages 1028-1040.
Crossref
Arata Azuma. (2012) Pirfenidone treatment of idiopathic pulmonary fibrosis. Therapeutic Advances in Respiratory Disease 6:2, pages 107-114.
Crossref
K. M. Akgun, K. Crothers & M. Pisani. (2012) Epidemiology and Management of Common Pulmonary Diseases in Older Persons. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 67A:3, pages 276-291.
Crossref
Toby M. Maher. (2012) Idiopathic Pulmonary Fibrosis: Pathobiology of Novel Approaches to Treatment. Clinics in Chest Medicine 33:1, pages 69-83.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.